Алтынай Арысбекова

Алтынай Арысбекова

Auto-generated profile, based on publicly available information

Алтынай Арысбекова

Kazakh Scientific Research Veterinary Institute

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY: Veterinary sciences
Verified
Journal Article
Open access
PDF file
ФБФлюра Бакиева
Флюра Бакиева
RSRano Sattarova
Rano Sattarova
KSK. M. Shynybayev
K. M. Shynybayev
ZIZh. I. Issakulova
Zh. I. Issakulova
AIA. K. Ilimbayeva
A. K. Ilimbayeva
AAA.T. Arysbekova
A.T. Arysbekova
Background and Aim. The spread of moraxellosis in cattle among Kazakhstan has become a pressing issue in modern agricultural markets. Preventive measures are essential to mitigate economic losses. This study aimed to assess the immunogenic activity of a prototype inactivated autogenous antimoraxellosis vaccine developed from a local inactivated strain of the pathogen. Materials and Methods. An outbreak culture was isolated from an animal showing signs of infectious eye disease, which was identified as Moraxella bovis B-2017/44 based on its culture and morphological characteristics. This strain was used to produce an autogenous vaccine using Montanide ISA 70 VG oil adjuvant (France). The vaccine’s immunogenicity was tested via a prolonged complement fixation reaction in Aberdeen Angus calves. The immunogenic properties were evaluated in comparison with a vaccine for infectious bovine keratoconjunctivitis, which utilizes Moraxella bovis antigens and herpesvirus type I, created in Kazan, Russia. Results. The autogenous anti-moraxellosis vaccine with Montanide ISA 70 VG adjuvant was effective against moraxellosis in cattle. Sterility and safety were evaluated in laboratory animals, whereas immunogenicity was assessed in calves over 12 months. The highest antibody titers were recorded on day 120 after vaccination. Conclusion. The developed vaccine, based on the locally inactivated strain Moraxella bovis B-2017/44, enhances antiepizootic efforts and reduces economic losses from infectious keratoconjunctivitis in cattle.

25 March 2025 in Ġylym ža̋ne bìlìm
Verified
Journal Article
Open access
PDF file
RSRano Sattarova
Rano Sattarova
КБКарлыгаш Боранбаева
Карлыгаш Боранбаева
КШКуандык Шыныбаев
Куандык Шыныбаев
ФБФлюра Бакиева
Флюра Бакиева
АИАльмира Илимбаева
Альмира Илимбаева
ЛДЛилия Дуплева
Лилия Дуплева
В статье приведены результаты исследования инвазионного кератоконъюнктивита крупного рогатого скота в южном регионе Республики Казахстан. Телязиоз – гельминтоз, вызываемые нематодами Thelazia rhodesi, Thelazia gulosa и Thelazia skjabini, обитающими в конъюнктиве, слезных протоках и слезных железах сельскохозяйственных животных. Заболевание характеризуется воспалением слизистой оболочки и роговицы глаза, слезотечением, светобоязнью, гиперемией, местной болью, повышением температуры, помутнением роговицы глaзного яблокa, диcтрофичеcкими изменениями прилегaющей к нему облacти, в форме кaтaрaльного или фиброзно-гнойного керaтоконъюнктивитa, c поcледующим оcложнением, приводящим к частичной или полной потере зрения. За 2020-2021 годы клинически обследованы 500 голов крупного рогатого скота породы Казахская белоголовая, Абердин-ангус, Герефорд и 21 як в хозяйствующих субъектах Алматинской, Жетысуской, Туркестанской областей. Из 214 голов крупного рогатого скота с клиническими проявлениями кератоконъюнктивита при микроскопировании 40 из 154 образцов показали положительные результаты. Установлено, что нематоды относятся к виду Thelazia rhodesi. У яков с клиническими проявлениями кератоконъюнктивита, находившихся в одной эпизоотологической единице с другими сельскохозяйственными животными в предгорьях Иле-Алатауского национального парка, нематоды не обнаружены. Вызывают беспокойство экономические потери, вред причиняемый здоровью крупного рогатого скота телязиями. Возбудитель заболевания – нематоды телязий – сохраняют жизнеспособноть в течение года, вследствии чего нозоареал этого заболевания постоянно увеличиваются. Исходя из вышеизложеного необходимо разрабатывать и внедрять эффективные меры по повышению противоэпизоотических мероприятий.

18 September 2026 in Veterinary World
Verified
Journal Article
Open access
PDF file
MUMynbay Umitzhanov
Mynbay Umitzhanov
NBNurbol Bakirov
Nurbol Bakirov
ASAbylay Sansyzbay
Abylay Sansyzbay
ANAinur Nurpeisova
Ainur Nurpeisova
NANazym Akimzhan
Nazym Akimzhan
AAAltynai Arysbekova
Altynai Arysbekova
Background and Aim: Bovine trichophytosis is a contagious zoonotic dermatophytosis that adversely affects animal health and livestock productivity and poses an occupational risk to people in contact with infected cattle. Although live attenuated vaccines have contributed to disease control, evidence for bivalent formulations targeting multiple Trichophyton species remains limited. This study evaluated the prophylactic activity and post-infection outcomes of a live attenuated bivalent vaccine candidate containing Trichophyton verrucosum and a member of the Trichophyton mentagrophytes species complex in an experimental rabbit model. Materials and Methods: Thirty-three clinically healthy rabbits were allocated to a prophylactic group (Group I, n = 10), therapeutic group (Group IIa, n = 10), infected untreated histopathology subgroup (Group IIb, n = 3), and intact control group (Group III, n = 10). Group I received two intramuscular vaccinations 14 days apart and was challenged 21 days after the second vaccination, whereas Group IIa was experimentally infected before therapeutic vaccination. Clinical manifestations, body weight, rectal temperature, hematological parameters, mycological culture, and histopathological changes were evaluated. Clinical and histopathological assessments were descriptive and non-blinded. Results: Following experimental challenge, no clinically visible dermatophytosis lesions occurred in prophylactically vaccinated rabbits (0/10), whereas all infected untreated reference rabbits developed lesions (3/3; two-sided Fisher’s exact test, p = 0.0035), supporting prophylactic activity. Therapeutically vaccinated rabbits showed progressive regression of visible crusting and hair regrowth; however, the absence of a longitudinal untreated infected group and positive treatment comparator precluded attribution of recovery specifically to vaccination. Dermatophyte growth was recovered from challenged skin after 5–7 days, although species-specific identification and quantitative fungal burden were not determined. Hematological indices showed limited descriptive variation. Histopathology demonstrated inflammatory and degenerative cutaneous lesions in untreated infected rabbits and nonspecific reactive lymphoid changes in vaccinated animals. Conclusion: The live attenuated bivalent vaccine candidate demonstrated promising prophylactic activity against experimental dermatophytosis in rabbits. Post-infection clinical improvement provides preliminary evidence warranting further investigation but cannot establish therapeutic efficacy. Controlled studies in the target host should incorporate adequate comparator groups, standardized lesion scoring, quantitative and species-specific mycology, immunological endpoints, and comprehensive vaccine quality control and stability assessments before field application. Keywords: bivalent vaccine, bovine trichophytosis, dermatophytosis, live attenuated vaccine, One Health, rabbit model, Trichophyton mentagrophytes, Trichophyton verrucosum.

25 June 2023 in Ġylym ža̋ne bìlìm
Verified
Journal Article
Open access
PDF file
RSRano Sattarova
Rano Sattarova
ФБФлюра Бакиева
Флюра Бакиева
АИАльмира Илимбаева
Альмира Илимбаева
НАНурлан Акмырзаев
Нурлан Акмырзаев
АААлтынай Арысбекова
Алтынай Арысбекова
КШКуандык Шыныбаев
Куандык Шыныбаев
Мақалада Ақмола облысынының жеке шаруа қожалығында моракселлезбен ауырған бұзаудан бөлініп алынған Moraxella bovis B-2017/44 індеттік штаммынан дайындалған инактивтендірілген вакцинаның тәжірибелік үлгісінің иммуногендік белсенділігін экспериментальді жағдайларда зерттеу нәтижелері келтірілген. Вакцинаның иммуногендік көрсеткіші комплементті ұзақ байланыстыру реакциясында сыналып, тәжірибелік топтардағы бұзаулардың комплемент байланыстырушы антидене титрі бір жылға дейін сақталатындығы анықталды. Превентивті препараттың тәжірибелік үлгісі вакцинаға қойылатын стерильдік, залалсыздық, иммуногендік талаптарына сәйкес келді. Препараттың оңтайлы сақтау мерзімі 4-6°C-та 12 айды қамтыды. 6-18 айлық бұзаулардан іріктеліп алынған 26 бұзаудан тұратын екі тәжірибелік топтың алғашқысына вакцина тері астына, ал екінші топқа бұлшық етке иммунизацияланды. Бақылау тобындағы 27 бұзауға тек Montanide ISA 70 VG адъюванты тері астына егілді. Моракселлаға қарсы антидене титрінің ең жоғарғы көрсеткіші тері астына егілген тәжірибелік жануарларда 1:184 (+48,5%-32,7%), ал бұлшық етке егілген бұзауларда 1:160 (+30,1%,-23,1%) құрап, 12-ші айда 17 (+14,1% -12,3%) және 10 (+14,1% -12,3%) көрсетті. Бақылау тобындағы бұзауларда комплементті ұзақ байланыстыру реакциясында гемолиз тежелуі байқалмады. Иммунитет қарқындылығы 97%, ал иммунделмеген бақылау тобында індетті кератоконъюнктивиттің клиникалық көрінісі 77,5% жануарларда тіркелді.

17 July 2025 in Biosafety and Biotechnology
Verified
Journal Article
Open access
PDF file
MYM. Yusupov
M. Yusupov
ААА. Т. Арысбекова
А. Т. Арысбекова
KBK. S. Begasyl
K. S. Begasyl
AAA. A. Adambayeva
A. A. Adambayeva
RAR. B. Aitlesova
R. B. Aitlesova
ЖАЖ. С. Абай
Ж. С. Абай
This paper discusses the principles and methodology of validation of an analytical method based on high performance liquid chromatography (HPLC) used for quality control and quantitative determination of the active substance in an anthelmintic drug.Key validation parameters such as specificity, linearity, accuracy, precision, detection limit, and quantification limit are described. The analysis made it possible to confirm the compliance of the method with the requirements of regulatory documentation, which ensures its suitability for subsequent quality control of the drug. The results obtained indicate the high reliability and reproducibility of the HPLC method in the conditions of laboratory control of pharmaceutical products. It has been established that for all the parameters presented, the method meets the requirements of regulatory documents.